​

FibroBiologics (FBLG) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

FBLG Stock Forecast

FibroBiologics (FBLG) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $180.00, with a high of $180.00 and a low of $180.00. This represents a 23276.62% increase from the last price of $0.77.

- $40 $80 $120 $160 $200 High: $180 Avg: $180 Low: $180 Last Closed Price: $0.77

FBLG Stock Rating

FibroBiologics stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

FBLG Price Target Upside V Benchmarks

TypeNameUpside
StockFibroBiologics23276.62%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.77$0.77$0.77
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26-11--2
May, 26111--3
Apr, 26111--3
Mar, 2612---3
Feb, 2612---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 30, 2024Jason KolbertEF Hutton$9.00$2.88212.50%1068.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 16, 2026H.C. WainwrightBuyBuyhold
Feb 26, 2026H.C. WainwrightBuyBuyhold
Jan 02, 2026H.C. WainwrightBuyBuyhold
Nov 05, 2025H.C. WainwrightBuyBuyhold
Aug 05, 2025H.C. WainwrightBuyBuyhold
Oct 30, 2024H.C. WainwrightBuyinitialise
Sep 04, 2024EF HuttonBuyinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.59$-0.34$-0.42--
Avg Forecast$-0.65$-0.34$-0.38$-0.48$-0.68
High Forecast$-0.65$-0.33$-0.29$-0.29$-0.41
Low Forecast$-0.65$-0.35$-0.46$-0.66$-0.84
Surprise %-9.23%-10.53%--

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported-----
Avg Forecast-----
High Forecast-----
Low Forecast-----
Surprise %-----

Net Income Forecast

$-25M $-21M $-17M $-13M $-9M $-5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-16.48M$-11.16M$-18.65M--
Avg Forecast$-18.27M$-9.60M$-10.59M$-13.41M$-17.64M
High Forecast$-18.27M$-9.32M$-8.19M$-8.19M$-11.57M
Low Forecast$-18.27M$-9.88M$-12.99M$-18.63M$-23.71M
Surprise %-9.79%16.28%76.13%--

FBLG Forecast FAQ

Is FibroBiologics stock a buy?

FibroBiologics stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that FibroBiologics is a favorable investment for most analysts.

What is FibroBiologics's price target?

FibroBiologics's price target, set by 4 Wall Street analysts, averages $180 over the next 12 months. The price target range spans from $180 at the low end to $180 at the high end, suggesting a potential 23276.62% change from the previous closing price of $0.77.

How does FibroBiologics stock forecast compare to its benchmarks?

FibroBiologics's stock forecast shows a 23276.62% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for FibroBiologics over the past three months?

  • June 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is FibroBiologics’s EPS forecast?

FibroBiologics's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.48, marking a 14.29% increase from the reported $-0.42 in 2025. Estimates for the following years are.

What is FibroBiologics’s revenue forecast?

FibroBiologics's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for.

What is FibroBiologics’s net income forecast?

FibroBiologics's net income forecast for the fiscal year ending in December 2026 stands at $-13.41M, representing a -28.08% decrease from the reported $-18.646M in 2025. Projections indicate .